Bio-Matrix and Entest BioMedical sign contract with UCLA researcher
Dr Koos is the developer of a screening test for gestational diabetes licensed to Entest BioMedical by University of California, Los Angeles (UCLA). The screening test is believed
Voro Therapeutics and Alloy Therapeutics have formed a strategic research partnership to develop tumour-selective, next-generation masked T-cell engager (TCE) therapeutics.
Impulse Monitoring will provide Nash Health Care with comprehensive intraoperative neurophysiological monitoring (IONM) services, including real-time professional oversight by experienced physicians. IONM assesses neurological function involving the brain,